Glomerular Disorders and Kidney Disease Outcomes
Summary
Glomerular disorders encompass a range of diseases affecting the glomeruli, the specialised capillary tufts that initiate blood filtration in the kidney. These conditions, which include entities such as lupus nephritis, IgA nephropathy and diabetic nephropathy, contribute substantially to the global burden of chronic kidney disease (CKD) and end-stage kidney disease (ESKD). Clinical outcomes are determined by histological lesion type, degree of proteinuria, immunological activity and comorbidities such as hypertension and diabetes. Recent advances in risk stratification have incorporated biomarkers and competing-risk modelling to predict progression to dialysis and premature mortality. Therapeutic innovations, from targeted immunomodulation to metabolic interventions, are reshaping the management landscape, while recognition of the interplay between renal injury and cardiovascular risk underscores the need for integrated care pathways.
Research from Nature Portfolio
Recent studies have applied years of potential life lost (YLL) metrics to quantify the burden of biopsy-proven glomerular disease within specific populations. In a Southeast Asian cohort, YLL analysis revealed that lupus nephritis, although not the leading cause of mortality or ESKD by absolute rates, accounted for the largest share of premature death before age 60. This approach has highlighted discrepancies between conventional outcome measures and societal burden, drawing attention to subtypes that merit intensified monitoring and targeted therapies. Concurrently, refinements in competing-risk frameworks have improved prognostic precision by modelling the likelihood of dialysis initiation against mortality.
Glomerular Disorders and Kidney Disease Outcomes publication trend
The graph below shows the total number of articles in glomerular disorders and kidney disease outcomes across all publications each year (not limited to Nature Index journals).
Technical terms
Glomerulus: A capillary tuft within the nephron responsible for the initial filtration of blood in the kidney.
Proteinuria: Abnormal excretion of protein in the urine, typically reflecting glomerular barrier impairment.
End-stage kidney disease (ESKD): The final stage of CKD at which renal replacement therapy (dialysis or transplantation) is required.
Years of potential life lost (YLL): A measure estimating the number of years lost due to premature death relative to life expectancy.
Troponin I and NT-proBNP: Cardiac biomarkers indicative of myocardial injury and cardiac stress, respectively, used for cardiovascular risk stratification.
References
- Years of life lost and long-term outcomes due to glomerular disease in a Southeast Asian Cohort. Scientific Reports (2023).
- The Bidirectional Link Between Diabetes and Kidney Disease: Mechanisms and Management. Cureus (2023).
- Routine cardiac biomarkers for the prediction of incident major adverse cardiac events in patients with glomerulonephritis: a real-world analysis using a global federated database. BMC Nephrology (2024).
- Assessment of atherosclerosis and endothelial dysfunction risk factors in patients with primary glomerulonephritis. Brazilian Journal of Nephrology (2024).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.